Navigation Links
NJ docs beat fed deadline: Signing up in droves for electronic health records
Date:11/17/2011

emonstrate the value of EHR adoption, we look forward to the rest of the state's practitioners joining the movement and then our state's eight million residents will begin to see how this movement will result in reduced cost and improved quality of healthcare delivery."

The grant's next phase will be to assist NJ-HITEC's primary care providers utilize their EHR systems to meet the federal criteria of "meaningful use" established by the Centers for Medicare and Medicaid (CMS). "NJ-HITEC will now commence a provider-centered focus to assist each doctor to select a fully accredited EHR system and work intensively with these physicians and their staff to demonstrate the proper way to use these systems to benefit the patient and the practice," added O'Byrne.

"This phase of work will continue until 2015 as it is expected that electronic health information technology will increasingly become a part of how high quality healthcare is delivered to Americans. Ultimately, every patient will have an interoperable, safe, and secure electronic health record that is accessible in a nationwide interoperable health information network."

NJ-HITEC is one of 62 federally designated Regional Extension Centers (REC) nationwide established to improve American healthcare delivery and patient care through the investment in health information technology. As New Jersey's lone REC, O'Byrne recognizes the scope of work ahead of NJ-HITEC as well as those organizations that have helped in its success including NJIT and the State of New Jersey.

NJ-HITEC provides support and assistance to New Jersey's primary care providers in the selection, implementation, and achievement of "meaningful use" of an ONC accredited Electronic Health Record (EHR) system. NJ-HITEC is the federally designated Regional Extension Center (REC) for New Jersey established by NJIT through a grant from the U.S. Department of Health and Human Services.


'/>"/>

Contact: Denise Anderson
732-618-3867
New Jersey Institute of Technology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Rocketboy Media Wins Award for Masonic Lodge Web Site; Announces Signing of Several New Clients
2. GlobalSign Releases Code Signing Certificates for Individual Software Developers
3. Champion Nutrition Announces the Signing of Brian Bowles
4. Signing Documents Online, Now Available for Telecom NZ Business Hub Customers
5. The Dawson Academy Announces the Signing of a Joint Marketing Agreement with Ads Next™
6. Structure of key molecule in immune system provides clues for designing drugs
7. Former astronaut Bernard Harris visits UH for book signing, lecture
8. What to Look for When Selecting an Electronic Health Record for Your Community Oncology Practice - Free Educational Webinar
9. Digital Signatures Presented at Electronic Document Management Conference
10. Compex , Leaders in Electronic Muscle Stimulators, Sponsors the Jelly Belly Cycling Team Presented by Kenda
11. Electronic Interconnect Offers Medical Electronics, PCBs, Design Engineering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Scientists have identified the first genetic variant specifically ... sub-type accounting for around 10-15 per cent of ... study of the breast cancer sub-type, called invasive ... genetic causes of this particular kind of breast ... The research, published today (Thursday) in the journal ...
(Date:4/17/2014)... the most popular vaccine brands for children may not ... overlooking some cost factors when choosing vaccines, driving the ... according to a new study by University of Illinois ... be driven by numerous factors," says Sheldon H. Jacobson, ... computer science and of mathematics at the U. of ...
(Date:4/17/2014)... Biology and Medicine a multidisciplinary research team ... in the Institute of Genomic Biology (IGB) on ... describe their recent work on subcellular redox homeostasis. ... functions including energy metabolism, signaling, and transcriptional processes. ... cellular behavior, redox status has been recognized as ...
(Date:4/17/2014)... Two recent papers by a University of ... help scientists develop treatments or vaccines for Dengue ... and other disease-causing flaviviruses. , Jeffrey S. Kieft, ... at the School of Medicine and an early ... and colleagues recently published articles in the scholarly ...
(Date:4/17/2014)... Pediatrician-in-Chief Jon McCullers, MD, was recently invited to ... Nature Reviews Microbiology , one of the ... world-renowned infectious disease specialist, and chair of the ... Health Science Center, analyzed the epidemiology and microbiology ... pandemics, as well as more recent 2009 novel ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study recalculates costs of combination vaccines 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:CU researchers discover target for treating dengue fever 2
... Bill Germanakos to Deliver NBGH Keynote Address, ... DGX ), the leading provider of diagnostic ... Business Group,on Health (NBGH), an association of more ... Best Employers for Healthy Lifestyles Gold Award to ...
... with seizures, SEATTLE, May 13 The Epilepsy ... in,Seattle, Spokane and Portland. The events will occur on ... Spokane at Riverfront Park. The following,day, Sunday, June 22, ... take place from 9:30 am-12:00 pm., "Everyone is ...
... 13 The Board of Directors of,MSA (NYSE: MSA ... per,share on common stock, payable June 10, 2008 to shareholders ... a dividend of 56-1/4 cents per share on,preferred stock, payable ... About MSA:, Established in 1914, MSA is a ...
... tobacco smoke respond particularly well to montelukast (Singulair) ... Research Center. Associate Professor of Pediatrics Nathan ... biomarkers that may help physicians predict even more ... These findings will help doctors know in advance ...
... Center,for Adoption announces a $10,000 grant from the Aetna ... during pregnancy., Kimberlee Walters-Sanders, an Aetna sales representative ... Head of Sales, will,present the award to Gladney staff ... Gladney,s campus, located at 6300 John Ryan Dr., Fort,Worth., ...
... Both Proposals -, LAKE FOREST, Ill., May 13 ... specialty pharmaceutical and medication,delivery company, today held its 2008 ... votes on two proposals and a brief,update on the ... to the success of our strategies of investing,for growth, ...
Cached Medicine News:Health News:Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' 2Health News:Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' 3Health News:Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' 4Health News:Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' 5Health News:Girls and children exposed to tobacco smoke benefit more from montelukast (singulair) 2Health News:Gladney Center for Adoption Receives Whole Health Grant from Aetna Foundation 2Health News:Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders 2
(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014  Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity.  These results ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North America,s ... of high-value chemistry, will hold the 30 th edition ... Convention Center from January 21-24. (Logo: ... from top pharmaceutical, fine chemical and specialty chemical companies will ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Bone Curette, 180 mm...
Endocrette Endocervical Curette is a stainless-steel curette with closed blade....
Townsend is a endocervical stainless-steel curette with round tapered tip....
Kevorkian Endocervical Curette is a stainless-steel curette with a basket. It is narrow tipped for sampling without dilation....
Medicine Products: